Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/16/1/90/435009/mdi018.pdf
Reference27 articles.
1. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC Cancer Base No 5;Ferlay,2001
2. Chemotherapy of lung cancer;Ihde;N Engl J Med,1992
3. Cancer Statistics, 2004;Jemal;CA Cancer J Clin,2004
4. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;Non-small Cell Lung Cancer Collaborative Group;BMJ,1995
5. American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline Update 2003;Pfister;J Clin Oncol,2004
Cited by 558 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Considering molecular alterations as pan-cancer tissue-agnostic targets;Nature Cancer;2023-12-15
2. Advances in protein kinase drug discovery through targeting gatekeeper mutations;Expert Opinion on Drug Discovery;2023-10-09
3. Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas;Cancer;2023-09-28
4. TRKing sarcomas for precision medicine: Seek, and ye shall find!;Cancer;2023-09-28
5. Precision medicine in Thoracic Oncology: understanding disparities to tackle inequities in access;Expert Review of Pharmacoeconomics & Outcomes Research;2023-09-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3